Cargando…

What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme

BACKGROUND: MicroRNAs (miRNAs) are short non-protein-coding RNA species that have a regulatory function in modulating protein translation and degradation of specific mRNAs. MicroRNAs are estimated to target approximately 60 % of all human mRNAs and are associated with the regulation of all physiolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonge, D. P., Gant, T. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748454/
https://www.ncbi.nlm.nih.gov/pubmed/26860190
http://dx.doi.org/10.1186/s12867-016-0057-9
_version_ 1782415117843955712
author Tonge, D. P.
Gant, T. W.
author_facet Tonge, D. P.
Gant, T. W.
author_sort Tonge, D. P.
collection PubMed
description BACKGROUND: MicroRNAs (miRNAs) are short non-protein-coding RNA species that have a regulatory function in modulating protein translation and degradation of specific mRNAs. MicroRNAs are estimated to target approximately 60 % of all human mRNAs and are associated with the regulation of all physiological processes. Similar to many messenger RNAs (mRNA), miRNAs exhibit marked tissue specificity, and appear to be dysregulated in response to specific pathological conditions. Perhaps, one of the most significant findings is that miRNAs are detectable in various biological fluids and are stable during routine clinical processing, paving the way for their use as novel biomarkers. Despite an increasing number of publications reporting individual miRNAs or miRNA signatures to be diagnostic of disease or indicative of response to therapy, there is still a paucity of baseline data necessary for their validation. To this end, we utilised state of the art sequencing technologies to determine the global expression of all circulating miRNAs within the plasma of 18 disease-free human subjects. RESULTS: In excess of 500 miRNAs were detected in our study population with expression levels across several orders of magnitude. Ten highly expressed miRNAs accounted for 90 % of the total reads that mapped showing that despite the range of miRNAs present, the total miRNA load of the plasma was predominated by just these few species (50 % of which are blood cell associated). Ranges of expression were determined for all miRNA detected (>500) and a set of highly stable miRNAs identified. Finally, the effects of gender, smoking status and body mass index on miRNA expression were determined. CONCLUSIONS: The data contained within will be of particular use to researchers performing miRNA-based biomarker screening in plasma and allow shortlisting of candidates a priori to expedite discovery or reduce costs as required. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12867-016-0057-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4748454
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47484542016-02-11 What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme Tonge, D. P. Gant, T. W. BMC Mol Biol Research Article BACKGROUND: MicroRNAs (miRNAs) are short non-protein-coding RNA species that have a regulatory function in modulating protein translation and degradation of specific mRNAs. MicroRNAs are estimated to target approximately 60 % of all human mRNAs and are associated with the regulation of all physiological processes. Similar to many messenger RNAs (mRNA), miRNAs exhibit marked tissue specificity, and appear to be dysregulated in response to specific pathological conditions. Perhaps, one of the most significant findings is that miRNAs are detectable in various biological fluids and are stable during routine clinical processing, paving the way for their use as novel biomarkers. Despite an increasing number of publications reporting individual miRNAs or miRNA signatures to be diagnostic of disease or indicative of response to therapy, there is still a paucity of baseline data necessary for their validation. To this end, we utilised state of the art sequencing technologies to determine the global expression of all circulating miRNAs within the plasma of 18 disease-free human subjects. RESULTS: In excess of 500 miRNAs were detected in our study population with expression levels across several orders of magnitude. Ten highly expressed miRNAs accounted for 90 % of the total reads that mapped showing that despite the range of miRNAs present, the total miRNA load of the plasma was predominated by just these few species (50 % of which are blood cell associated). Ranges of expression were determined for all miRNA detected (>500) and a set of highly stable miRNAs identified. Finally, the effects of gender, smoking status and body mass index on miRNA expression were determined. CONCLUSIONS: The data contained within will be of particular use to researchers performing miRNA-based biomarker screening in plasma and allow shortlisting of candidates a priori to expedite discovery or reduce costs as required. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12867-016-0057-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-09 /pmc/articles/PMC4748454/ /pubmed/26860190 http://dx.doi.org/10.1186/s12867-016-0057-9 Text en © Tonge and Gant. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tonge, D. P.
Gant, T. W.
What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme
title What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme
title_full What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme
title_fullStr What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme
title_full_unstemmed What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme
title_short What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme
title_sort what is normal? next generation sequencing-driven analysis of the human circulating mirnaome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748454/
https://www.ncbi.nlm.nih.gov/pubmed/26860190
http://dx.doi.org/10.1186/s12867-016-0057-9
work_keys_str_mv AT tongedp whatisnormalnextgenerationsequencingdrivenanalysisofthehumancirculatingmirnaome
AT ganttw whatisnormalnextgenerationsequencingdrivenanalysisofthehumancirculatingmirnaome